SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 49,250
+700 (1.44%)
Jan 22, 2026, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.81 trillion as of January 22, 2026. Its market cap has decreased by -7.42% in one year.
Market Cap
3.81T
Enterprise Value
3.45T
Revenue
624.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
49,250.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.81T, a decrease of -70.55%. That is a compound annual growth rate of -22.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 3.86T | 2.24% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | 12.93T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 88.92T |
| Celltrion | 45.73T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 7.91T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.43T |